0QLX Stock Overview
Through its subsidiaries, engages in the medical devices, infection control, technology cluster and infrastructure, and other businesses in Switzerland, rest of Europe, the Americas, the Asia Pacific, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 1/6 |
Metall Zug AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF 1,245.00 |
| 52 Week High | CHF 1,650.00 |
| 52 Week Low | CHF 1,225.00 |
| Beta | 0.95 |
| 11 Month Change | -7.78% |
| 3 Month Change | -5.68% |
| 1 Year Change | -23.85% |
| 33 Year Change | -41.00% |
| 5 Year Change | -43.67% |
| Change since IPO | -69.38% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0QLX | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | -1.2% | -1.7% | -0.9% |
| 1Y | -23.9% | -13.2% | 6.3% |
Return vs Industry: 0QLX underperformed the UK Medical Equipment industry which returned -13.2% over the past year.
Return vs Market: 0QLX underperformed the UK Market which returned 6.3% over the past year.
Price Volatility
| 0QLX volatility | |
|---|---|
| 0QLX Average Weekly Movement | 4.0% |
| Medical Equipment Industry Average Movement | 5.9% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 10.9% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0QLX has not had significant price volatility in the past 3 months.
Volatility Over Time: 0QLX's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1887 | 2,224 | Matthias Rey | www.metallzug.ch |
Metall Zug AG, through its subsidiaries, engages in the medical devices, infection control, technology cluster and infrastructure, and other businesses in Switzerland, rest of Europe, the Americas, the Asia Pacific, and internationally. The company offers medical and surgical instrument sterilization, disinfection, and cleaning product and service solutions. It also develops, produces, and distributes devices and solutions for medical diagnosis, microsurgery, and eye care specialist; and offers diagnostics equipment, such as slit lamps, perimetry, and biometry for cataract diagnosis and treatment; equipment for ophthalmologists, including stands, chairs, industrial high-precision surgical microscopes, and other accessories; and augmented reality technology and digital imaging for the eye care specialists.
Metall Zug AG Fundamentals Summary
| 0QLX fundamental statistics | |
|---|---|
| Market cap | CHF 555.75m |
| Earnings (TTM) | CHF 22.22m |
| Revenue (TTM) | CHF 494.72m |
25.0x
P/E Ratio1.1x
P/S RatioIs 0QLX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0QLX income statement (TTM) | |
|---|---|
| Revenue | CHF 494.72m |
| Cost of Revenue | CHF 343.06m |
| Gross Profit | CHF 151.65m |
| Other Expenses | CHF 129.44m |
| Earnings | CHF 22.22m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Aug 19, 2024
| Earnings per share (EPS) | 49.37 |
| Gross Margin | 30.65% |
| Net Profit Margin | 4.49% |
| Debt/Equity Ratio | 7.0% |
How did 0QLX perform over the long term?
See historical performance and comparison